Blue Barn Wealth’s LeMaitre Vascular LMAT Stock Holding History

Blue Barn Wealth’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,473	Closed	-$216K	–	106
2025 Q3	$216K	Buy	+2,473	New	+$221K	0.1%	154
2025 Q1	–	Sell	-2,485	Closed	-$229K	–	157
2024 Q4	$229K	Buy	2,485 +104	+4%	+$10K	0.12%	128
2024 Q3	$221K	Buy	+2,381	New	+$206K	0.11%	138

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Blue Barn Wealth's LMAT Position: Q4 2025 in Review

Blue Barn Wealth sold out of LeMaitre Vascular (LMAT) in Q4 2025, closing a stake of 2,473 shares — an estimated $216K sold.

Blue Barn Wealth first reported a position in LMAT in Q3 2024 and held it in 3 quarters. The position peaked at $229K in Q4 2024. 297 funds tracked by Wall St. Rank hold LMAT as of Q4 2025.

Blue Barn Wealth reported no remaining LeMaitre Vascular position as of Q4 2025 after selling out during the quarter.
Blue Barn Wealth sold 2,473 LeMaitre Vascular shares in Q4 2025, an estimated $216K.
Blue Barn Wealth first reported a position in LeMaitre Vascular in Q3 2024 and held it in 3 quarters.
Blue Barn Wealth's LeMaitre Vascular position peaked at $229K in Q4 2024.
297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2025.

Based on Blue Barn Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.